April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
In situ Polymeric Biodegradable Gelling Systems of Steroids for the Treatment of Retinal Diseases
Author Affiliations & Notes
  • S. H. Boddu
    Pharmaceutical Sciences, University of Missouri, Kansas City, Missouri
  • J. Jwala
    Pharmaceutical Sciences, University of Missouri, Kansas City, Missouri
  • R. Vaishya
    Pharmaceutical Sciences, University of Missouri, Kansas City, Missouri
  • D. Pal
    Pharmaceutical Sciences, University of Missouri, Kansas City, Missouri
  • A. K. Mitra
    Pharmaceutical Sciences, University of Missouri, Kansas City, Missouri
  • Footnotes
    Commercial Relationships  S.H. Boddu, None; J. Jwala, None; R. Vaishya, None; D. Pal, None; A.K. Mitra, None.
  • Footnotes
    Support  R01 EY 09171-14 and R01 EY 10659-12
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5966. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. H. Boddu, J. Jwala, R. Vaishya, D. Pal, A. K. Mitra; In situ Polymeric Biodegradable Gelling Systems of Steroids for the Treatment of Retinal Diseases. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5966.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Repeated intravitreal injections of steroids in the treatment of retinal diseases pose potential problems like retinal detachment, hemorrhage, endophthalmitis, lack of patient compliance and risk of drug precipitation due to poor solubility. The aim of this study is to develop a novel biodegradable injectable in situ gelling system which can be subconjunctivally administered for the treatment of retinal diseases.

Methods: : Steroidal nanoparticles of dexamethasone (DEX), hydrocortisone acetate (HA) and prednisolone acetate (PA) were prepared with PLGA 50:50 and PLGA 65:35 by dialysis method and O/W emulsion/solvent evaporation methods. Nanoparticles were studied for size, entrapment efficiency,crystallinity, surface morphology, release properties and time dependent cytotoxicity. .

Results: : O/W emulsion/solvent evaporation method resulted in higher entrapment efficiencies compared to dialysis method. Hence, nanoparticles prepared by emulsion technique were used for further studies. Entrapment efficiencies were found to be 78.2%, 93.1% and 93.6% for DEX, HA and PA respectively. Sustained release of steroids was observed from the nanoparticles prepared by O/W emulsion/solvent evaporation method and release rate constants for DEX, HA and PA were found to be 6.73, 2.24, 3.40 h-1/2 respectively. The release rate constants of DEX, HA and PA from PLGA 65:35 nanoparticles were found to be 5.11, 1.31 and 3.16 h-1/2 respectively. Such nanoparticles were suspended in biodegradable thermosensitive polymeric (PLGA-PEG-PLGA) gels for subconjunctival administration. PLGA-PEG-PLGA was synthesized and characterized for its swelling properties, thermogelling behavior and rheology. Stability studies of steroidal nanoparticles along with PLGA-PEG-PLGA were carried out in glass vials at 25°C ± 2°C, 30°C ± 2°C and 40°C ± 2°C as per the ICH guidelines. Final formulations were prepared by suspending required quantity of nanoparticles in 23% W/W aqueous solution of PLGA-PEG-PLGA polymer. This mixture was freeze dried and sterilized in vials for future reconstitution.

Conclusions: : Novel gelling nanoparticle based drug delivery system may provide sustained delivery of steroids following a single episcleral administration.

Keywords: corticosteroids • retina • choroid 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×